Rare-Disease Drugs.
In: Beijing Review, Jg. 64 (2021-12-30), Heft 52, S. 5-5
serialPeriodical
Zugriff:
Seven rare-disease drugs have been added to the list in 2021, bringing their price down by about 65 percent on average, Li Tao, an official with the National Healthcare Security Administration, said at the conference. China's medicare reimbursement list now covers medications for 25 rare diseases, according to figures released at a national conference on rare diseases in Beijing on December 18. More than 60 rare-disease drugs have been approved for marketing in China, over 40 of which are included in the national medical insurance system, according to official data. [Extracted from the article]
Titel: |
Rare-Disease Drugs.
|
---|---|
Zeitschrift: | Beijing Review, Jg. 64 (2021-12-30), Heft 52, S. 5-5 |
Veröffentlichung: | 2021 |
Medientyp: | serialPeriodical |
ISSN: | 1000-9140 (print) |
Schlagwort: |
|
Sonstiges: |
|